Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
21 09 2021
Historique:
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 29 12 2021
Statut: ppublish

Résumé

Early detection of coronary atherosclerosis using coronary computed tomography angiography (CCTA), in addition to coronary artery calcification (CAC) scoring, may help inform prevention strategies. We used CCTA to determine the prevalence, severity, and characteristics of coronary atherosclerosis and its association with CAC scores in a general population. We recruited 30 154 randomly invited individuals age 50 to 64 years to SCAPIS (the Swedish Cardiopulmonary Bioimage Study). The study includes individuals without known coronary heart disease (ie, no previous myocardial infarctions or cardiac procedures) and with high-quality results from CCTA and CAC imaging performed using dedicated dual-source CT scanners. Noncontrast images were scored for CAC. CCTA images were visually read and scored for coronary atherosclerosis per segment (defined as no atherosclerosis, 1% to 49% stenosis, or ≥50% stenosis). External validity of prevalence estimates was evaluated using inverse probability for participation weighting and Swedish register data. In total, 25 182 individuals without known coronary heart disease were included (50.6% women). Any CCTA-detected atherosclerosis was found in 42.1%; any significant stenosis (≥50%) in 5.2%; left main, proximal left anterior descending artery, or 3-vessel disease in 1.9%; and any noncalcified plaques in 8.3% of this population. Onset of atherosclerosis was delayed on average by 10 years in women. Atherosclerosis was more prevalent in older individuals and predominantly found in the proximal left anterior descending artery. Prevalence of CCTA-detected atherosclerosis increased with increasing CAC scores. Among those with a CAC score >400, all had atherosclerosis and 45.7% had significant stenosis. In those with 0 CAC, 5.5% had atherosclerosis and 0.4% had significant stenosis. In participants with 0 CAC and intermediate 10-year risk of atherosclerotic cardiovascular disease according to the pooled cohort equation, 9.2% had CCTA-verified atherosclerosis. Prevalence estimates had excellent external validity and changed marginally when adjusted to the age-matched Swedish background population. Using CCTA in a large, random sample of the general population without established disease, we showed that silent coronary atherosclerosis is common in this population. High CAC scores convey a significant probability of substantial stenosis, and 0 CAC does not exclude atherosclerosis, particularly in those at higher baseline risk.

Sections du résumé

BACKGROUND
Early detection of coronary atherosclerosis using coronary computed tomography angiography (CCTA), in addition to coronary artery calcification (CAC) scoring, may help inform prevention strategies. We used CCTA to determine the prevalence, severity, and characteristics of coronary atherosclerosis and its association with CAC scores in a general population.
METHODS
We recruited 30 154 randomly invited individuals age 50 to 64 years to SCAPIS (the Swedish Cardiopulmonary Bioimage Study). The study includes individuals without known coronary heart disease (ie, no previous myocardial infarctions or cardiac procedures) and with high-quality results from CCTA and CAC imaging performed using dedicated dual-source CT scanners. Noncontrast images were scored for CAC. CCTA images were visually read and scored for coronary atherosclerosis per segment (defined as no atherosclerosis, 1% to 49% stenosis, or ≥50% stenosis). External validity of prevalence estimates was evaluated using inverse probability for participation weighting and Swedish register data.
RESULTS
In total, 25 182 individuals without known coronary heart disease were included (50.6% women). Any CCTA-detected atherosclerosis was found in 42.1%; any significant stenosis (≥50%) in 5.2%; left main, proximal left anterior descending artery, or 3-vessel disease in 1.9%; and any noncalcified plaques in 8.3% of this population. Onset of atherosclerosis was delayed on average by 10 years in women. Atherosclerosis was more prevalent in older individuals and predominantly found in the proximal left anterior descending artery. Prevalence of CCTA-detected atherosclerosis increased with increasing CAC scores. Among those with a CAC score >400, all had atherosclerosis and 45.7% had significant stenosis. In those with 0 CAC, 5.5% had atherosclerosis and 0.4% had significant stenosis. In participants with 0 CAC and intermediate 10-year risk of atherosclerotic cardiovascular disease according to the pooled cohort equation, 9.2% had CCTA-verified atherosclerosis. Prevalence estimates had excellent external validity and changed marginally when adjusted to the age-matched Swedish background population.
CONCLUSIONS
Using CCTA in a large, random sample of the general population without established disease, we showed that silent coronary atherosclerosis is common in this population. High CAC scores convey a significant probability of substantial stenosis, and 0 CAC does not exclude atherosclerosis, particularly in those at higher baseline risk.

Identifiants

pubmed: 34543072
doi: 10.1161/CIRCULATIONAHA.121.055340
pmc: PMC8448414
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

916-929

Commentaires et corrections

Type : CommentIn

Références

Am J Cardiol. 1983 Nov 1;52(8):921-6
pubmed: 6637847
N Engl J Med. 2018 Sep 06;379(10):924-933
pubmed: 30145934
Eur Radiol. 2002 Jun;12(6):1532-40
pubmed: 12042964
Int J Cardiovasc Imaging. 2005 Feb;21(1):39-53
pubmed: 15915939
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
J Cardiovasc Comput Tomogr. 2011 Mar-Apr;5(2):84-92
pubmed: 21477786
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
J Am Med Assoc. 1953 Jul 18;152(12):1090-3
pubmed: 13052433
J Am Coll Cardiol. 2020 Nov 24;76(21):2421-2432
pubmed: 33213720
J Am Coll Cardiol. 2010 Oct 19;56(17):1397-406
pubmed: 20946997
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C101-3
pubmed: 16631504
J Intern Med. 2021 Mar;289(3):309-324
pubmed: 33016506
JAMA. 1986 Nov 28;256(20):2863-6
pubmed: 3534337
J Am Coll Cardiol. 2008 Jul 29;52(5):357-65
pubmed: 18652943
Eur Heart J. 2004 Mar;25(6):484-91
pubmed: 15039128
Eur Heart J. 2020 Jan 1;41(1):12-85
pubmed: 31820000
Diagnostics (Basel). 2019 Sep 23;9(4):
pubmed: 31547506
Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):568-74
pubmed: 17667649
J Am Coll Cardiol. 2004 Sep 1;44(5):1011-7
pubmed: 15337212
J Clin Epidemiol. 2019 Apr;108:54-63
pubmed: 30562543
Circulation. 2007 Jan 23;115(3):402-26
pubmed: 17220398
Lancet. 2015 Jun 13;385(9985):2383-91
pubmed: 25788230
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Int J Cardiovasc Imaging. 2020 Dec;36(12):2305-2317
pubmed: 32076919
J Am Heart Assoc. 2018 Jun 28;7(13):
pubmed: 29954746
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Scand J Public Health. 2021 Jun;49(4):449-456
pubmed: 31826719
Eur Heart J. 2009 May;30(9):1046-56
pubmed: 19141562
J Am Coll Cardiol. 2010 Oct 19;56(17):1407-14
pubmed: 20946998
Mayo Clin Proc. 1999 Mar;74(3):243-52
pubmed: 10089993
JAMA Cardiol. 2018 Feb 1;3(2):144-152
pubmed: 29322167
PLoS One. 2016 May 05;11(5):e0154852
pubmed: 27149622
J Intern Med. 2015 Dec;278(6):645-59
pubmed: 26096600
J Am Coll Cardiol. 2005 Jul 19;46(2):383-402
pubmed: 16022977
Atherosclerosis. 2007 Nov;195(1):e207-16
pubmed: 17532322
Am J Epidemiol. 2017 Oct 15;186(8):1010-1014
pubmed: 28535275
Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):267-74
pubmed: 23966421
JAMA. 2012 Dec 26;308(24):2577-83
pubmed: 23268516
Circulation. 2005 Mar 15;111(10):1313-20
pubmed: 15769774
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
J Cardiovasc Comput Tomogr. 2017 Jul - Aug;11(4):258-267
pubmed: 28483581
Lab Invest. 1968 May;18(5):586-93
pubmed: 5681200
N Engl J Med. 2011 Jan 20;364(3):226-35
pubmed: 21247313
Acad Radiol. 2010 Aug;17(8):1001-5
pubmed: 20605733
N Engl J Med. 1997 May 1;336(18):1276-82
pubmed: 9113930
Nat Rev Cardiol. 2014 Jul;11(7):390-402
pubmed: 24755916
JACC Cardiovasc Imaging. 2018 Jan;11(1):127-142
pubmed: 29301708
J Cardiovasc Comput Tomogr. 2009 Mar-Apr;3(2):122-36
pubmed: 19272853
Int J Cardiovasc Imaging. 2015 Mar;31(3):659-68
pubmed: 25567747

Auteurs

Göran Bergström (G)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.
Departments of Clinical Physiology (G. Bergström, O.H.), Region Västra Götaland, Gothenburg, Sweden.

Margaretha Persson (M)

Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.
Departments of Internal Medicine (M.P.), Skåne University Hospital, Malmö, Sweden.

Martin Adiels (M)

Sahlgrenska Academy, and School of Public Health and Community Medicine, Institute of Medicine (M.A., C.B.), University of Gothenburg, Sweden.

Elias Björnson (E)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.

Carl Bonander (C)

Sahlgrenska Academy, and School of Public Health and Community Medicine, Institute of Medicine (M.A., C.B.), University of Gothenburg, Sweden.

Håkan Ahlström (H)

Section of Radiology, Department of Surgical Sciences (H.A., O.D.), Uppsala University, Sweden.

Joakim Alfredsson (J)

Departments of Cardiology (J.A., E.S.), Linköping University, Sweden.
Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.

Oskar Angerås (O)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.
Cardiology (O.A.), Region Västra Götaland, Gothenburg, Sweden.

Göran Berglund (G)

Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.

Anders Blomberg (A)

Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

John Brandberg (J)

Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.
Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden.

Mats Börjesson (M)

Institute of Medicine (M.B.), University of Gothenburg, Sweden.
Center for Health and Performance (M.B.), University of Gothenburg, Sweden.
Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden.

Kerstin Cederlund (K)

Department of Clinical Science, Intervention and Technology (K.C.), Karolinska Institutet, Stockholm, Sweden.

Ulf de Faire (U)

Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine (U.d.F.), Karolinska Institutet, Stockholm, Sweden.

Olov Duvernoy (O)

Section of Radiology, Department of Surgical Sciences (H.A., O.D.), Uppsala University, Sweden.

Örjan Ekblom (Ö)

Department of Physical Activity and Health, The Swedish School of Sport and Health Sciences (GIH), Stockholm, Sweden (Ö.E.).

Gunnar Engström (G)

Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.

Jan E Engvall (JE)

Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.
Clinical Physiology (J.E.E.), Linköping University, Sweden.
CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden.

Erika Fagman (E)

Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.
Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden.

Mats Eriksson (M)

Department of Endocrinology, Metabolism & Diabetes and Clinical Research Center, Karolinska University Hospital Huddinge, Stockholm, Sweden (M.E.).

David Erlinge (D)

Department of Clinical Sciences Lund, Cardiology, Lund University and Skåne University Hospital, Lund, Sweden (D.E., M.A.M.).

Björn Fagerberg (B)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.
Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden.

Agneta Flinck (A)

Department of Radiology, Institute of Clinical Sciences (J.B., E.F., A.F.), University of Gothenburg, Sweden.
Radiology (J.B., E.F., A.F.), Region Västra Götaland, Gothenburg, Sweden.

Isabel Gonçalves (I)

Department of Clinical Sciences Malmö (I.G.), Lund University and Skåne University Hospital, Lund, Sweden.

Emil Hagström (E)

Cardiology (E.H.), Uppsala University, Sweden.
Department of Medical Sciences, and Uppsala Clinical Research Center (E.H.), Uppsala University, Sweden.

Ola Hjelmgren (O)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.
Departments of Clinical Physiology (G. Bergström, O.H.), Region Västra Götaland, Gothenburg, Sweden.

Lars Lind (L)

Clinical Epidemiology (L.L., J.S.), Uppsala University, Sweden.

Eva Lindberg (E)

Respiratory, Allergy and Sleep Research (E.L.), Uppsala University, Sweden.

Per Lindqvist (P)

Department of Surgical and Perioperative Sciences (P.L.), Umeå University, Sweden.

Johan Ljungberg (J)

Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

Martin Magnusson (M)

Department of Clinical Sciences (M.P., G. Berglund, G.E., M. Magnusson), Lund University, Malmö, Sweden.
Cardiology (M. Magnusson), Skåne University Hospital, Malmö, Sweden.
Wallenberg Center for Molecular Medicine, Lund University, Sweden (M. Magnusson).
North-West University, Hypertension in Africa Research Team (HART), Potchefstroom, South Africa (M. Magnusson).

Maria Mannila (M)

Heart and Vascular Theme, Department of Cardiology, and Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden (M. Mannila).

Hanna Markstad (H)

Experimental Cardiovascular Research, Clinical Research Center, Clinical Sciences Malmö (H.M.), Lund University, Malmö, Sweden.
Center for Medical Imaging and Physiology (H.M.), Lund University and Skåne University Hospital, Lund, Sweden.

Moman A Mohammad (MA)

Department of Clinical Sciences Lund, Cardiology, Lund University and Skåne University Hospital, Lund, Sweden (D.E., M.A.M.).

Fredrik H Nystrom (FH)

Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.

Ellen Ostenfeld (E)

Department of Clinical Sciences Lund, Clinical Physiology (E.O.), Lund University and Skåne University Hospital, Lund, Sweden.

Anders Persson (A)

Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.
Radiology (A.P.), Linköping University, Sweden.
CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden.

Annika Rosengren (A)

Department of Molecular and Clinical Medicine (G. Bergström, E.B., O.A., B.F., O.H., A.R.), University of Gothenburg, Sweden.
Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden.

Anette Sandström (A)

Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

Anders Själander (A)

Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

Magnus C Sköld (MC)

Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine (M.C.S.), Karolinska Institutet, Stockholm, Sweden.
Department of Respiratory Medicine and Allergy, Karolinska University Hospital Solna, Stockholm, Sweden (M.C.S.).

Johan Sundström (J)

Clinical Epidemiology (L.L., J.S.), Uppsala University, Sweden.
The George Institute for Global Health, University of New South Wales, Sydney, Australia (J.S.).

Eva Swahn (E)

Departments of Cardiology (J.A., E.S.), Linköping University, Sweden.
Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, Medicine and Heart Centre (A.B., J.L., A. Sandström, A. Själander, S.S.), Umeå University, Sweden.

Kjell Torén (K)

Occupational and Environmental Medicine/School of Public Health and Community Medicine (K.T.), University of Gothenburg, Sweden.
Sahlgrenska University Hospital (M.B., B.F., A.R., K.T.), Region Västra Götaland, Gothenburg, Sweden.

Carl Johan Östgren (CJ)

Health, Medicine and Caring Sciences (J.A., E.S., J.E.E., F.H.N., C.J.Ö., A.P.), Linköping University, Sweden.
CMIV, Centre of Medical Image Science and Visualization (J.E.E., A.P., C.J.Ö.), Linköping University, Sweden.

Tomas Jernberg (T)

Department of Clinical Sciences, Danderyd University Hospital (T.J.), Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH